✦ LIBER ✦

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

✍ Scribed by Schoch, C; Kern, W; Schnittger, S; Hiddemann, W; Haferlach, T

Book ID: 110055715
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 166 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency and prognostic value of dysmye

Frequency and prognostic value of dysmyelopoiesis in 114 patients with de novo acute myeloid leukemia (AML) in an ongoing study

✍ T. Haferlach; H. Löffler; W. Gassmann; W.-D. Ludwig; E. Thiel; C. Fonatsch; B. S 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 153 KB

PRDX4, a member of the peroxiredoxin fam

PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22)

✍ Yanming Zhang; Neelmini Emmanuel; Ginny Kamboj; Jianjun Chen; Muhammad Shurafa; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 1 views

## Abstract The __AML1__ gene (also known as __RUNX1__) at 21q22 codes for core binding factor (CBF) α, which forms a heterodimer with CBF β that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definitive hematopoietic stem cells and